PropertyValue
nif:beginIndex
  • 0 (xsd:integer)
nif:broaderContext
nif:endIndex
  • 204 (xsd:integer)
nif:isString
  • Third-generation aromatase inhibitors, such as anastrozole, letrozole, and exemestane, have become the first-choice drug for endocrine treatment of hormone-sensitive breast cancer in postmenopausal women.
rdf:type